| The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models A Kotschy, Z Szlavik, J Murray, J Davidson, AL Maragno, ... Nature 538 (7626), 477-482, 2016 | 1046 | 2016 |
| Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction T Maurice, BP Lockhart, A Privat Brain research 706 (2), 181-193, 1996 | 667 | 1996 |
| Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands T Maurice, BP Lockhart Progress in Neuro-Psychopharmacology and Biological Psychiatry 21 (1), 69-102, 1997 | 289 | 1997 |
| A convenient extension of the Wessely–Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro R Larget, B Lockhart, P Renard, M Largeron Bioorganic & medicinal chemistry letters 10 (8), 835-838, 2000 | 150 | 2000 |
| Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures BP Lockhart, C Benicourt, JL Junien, A Privat Journal of neuroscience research 39 (4), 494-505, 1994 | 139 | 1994 |
| Only a subset of Met-activated pathways are required to sustain oncogene addiction A Bertotti, MF Burbridge, S Gastaldi, F Galimi, D Torti, E Medico, ... Science signaling 2 (100), ra80-ra80, 2009 | 103 | 2009 |
| Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA) B Di Cara, R Maggio, G Aloisi, JM Rivet, EG Lundius, T Yoshitake, ... Journal of Neuroscience 31 (47), 16928-16940, 2011 | 101 | 2011 |
| Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling M Bergé, D Allanic, P Bonnin, C de Montrion, J Richard, M Suc, JF Boivin, ... Journal of hepatology 55 (4), 866-875, 2011 | 99 | 2011 |
| S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab MF Burbridge, CJ Bossard, C Saunier, I Fejes, A Bruno, S Léonce, G Ferry, ... Molecular cancer therapeutics 12 (9), 1749-1762, 2013 | 95 | 2013 |
| New quinolinic derivatives as centrally active antioxidants G Dorey, B Lockhart, P Lestage, P Casara Bioorganic & Medicinal Chemistry Letters 10 (9), 935-939, 2000 | 95 | 2000 |
| Synthesis and in vitro evaluation of new 8-amino-1, 4-benzoxazine derivatives as neuroprotective antioxidants M Largeron, B Lockhart, B Pfeiffer, MB Fleury Journal of medicinal chemistry 42 (24), 5043-5052, 1999 | 91 | 1999 |
| Distinct neuroprotective profiles for σ ligands against N-methyl-d-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies BP Lockhart, P Soulard, C Benicourt, A Privat, JL Junien Brain research 675 (1-2), 110-120, 1995 | 84 | 1995 |
| Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells A Jaulmes, P Sansilvestri-Morel, G Rolland-Valognes, F Bernhardt, ... Thrombosis research 124 (4), 439-446, 2009 | 71 | 2009 |
| Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? BP Lockhart, PJ Lestage Experimental gerontology 38 (1-2), 119-128, 2003 | 69 | 2003 |
| Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine BP Lockhart, N Tordo, H Tsiang Antimicrobial agents and chemotherapy 36 (8), 1750-1755, 1992 | 69 | 1992 |
| Reversion of β25–35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists T Maurice, BP Lockhart, TP Su, A Privat Brain research 731 (1-2), 249-253, 1996 | 68 | 1996 |
| Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones C Volonte, MT Ciotti, N D’Ambrosi, B Lockhart, M Spedding Neuropharmacology 38 (9), 1335-1342, 1999 | 65 | 1999 |
| Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones A Dhainaut, A Tizot, E Raimbaud, B Lockhart, P Lestage, S Goldstein Journal of medicinal chemistry 43 (11), 2165-2175, 2000 | 62 | 2000 |
| Novel 2-alkylamino-1, 4-benzoxazine derivatives as potent neuroprotective agents: structure− activity relationship studies E Blattes, B Lockhart, P Lestage, L Schwendimann, P Gressens, ... Journal of medicinal chemistry 48 (4), 1282-1286, 2005 | 60 | 2005 |
| Exploring Functional β-Cell Heterogeneity In Vivo Using PSA-NCAM as a Specific Marker M Karaca, J Castel, C Tourrel-Cuzin, M Brun, A Géant, M Dubois, ... PLoS One 4 (5), e5555, 2009 | 56 | 2009 |
